Sperm pirna and sperm protein mitopld as biomarkers for detection and prediction of male infertility
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 南京碳硅人工智能生物医药技术研究院有限公司
- Publication Date
- 2020-04-24
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and relates to sperm piRNA and sperm protein MitoPLD as biomarkers for detecting and predicting male infertility. Background technique
[0002] Infertility has become a worldwide reproductive health problem. Currently, more than 15% of couples in the world suffer from infertility problems (1,2). Among them, about 20% to 30% of infertility is caused by male factors alone, and 50% of infertility is related to male factors. In recent years, this data has been on the rise (2,3), so male infertility Infertility plays an important role, however, the molecular mechanism of male infertility is not fully understood (4,5). At present, the clinical reproductive laboratory inspection items generally include biochemical inspection of semen, acid phosphatase, lactate dehydrogenase-X and other enzyme inspections, and semen immunological inspection, but these technologies have some defects and cannot directly refl...